After IPO, JECX Targets Profit Growth, Focuses on Building Eye Clinic in KEK Sanur

2026-07-08

After IPO JECX Targets Profit Growth, Focuses on Building Eye Clinic in KEK Sanur.png

After officially becoming a public company, the next step awaited by investors is how PT Nitrasanata Dharma Tbk (JECX) will utilize the proceeds from its initial public offering (IPO).

Amid optimism surrounding the JECX IPO, management has immediately set a target for JECX 2026 net profit growth of around 10% while accelerating the construction of JEC Bali in the Special Economic Zone (KEK) Sanur.

This strategy shows that the company is not only focused on short-term growth but is also strengthening its eye health services business position in the coming years.

Key Takeaways

  • JECX targets net profit growth of around 10% in 2026 through an increase in the number of patients and operational efficiency.
  • IPO proceeds are used to strengthen the financial structure, working capital, and construction of JEC Bali in KEK Sanur.
  • KEK Sanur is a strategic project as it is projected to become a center for medical tourism in Indonesia.

JECX Targets 10% Profit Growth After IPO

Management of PT Nitrasanata Dharma Tbk targets net profit growth of around 10% throughout 2026 after successfully listing its shares on the Indonesia Stock Exchange.

According to a report from Infobank, this target will be supported by an increase in the number of patients, operational cost efficiency, and optimization of services across the existing hospital and clinic network.

In addition to pursuing profit growth, the company also aims for revenue of around Rp1 trillion.

Start investing and trading tokenized stocks on Bittime with a fast, secure, and easy process.

IPO JECX IDX Channel.webp

Source: IDX

This target is considered realistic given that demand for eye health services in Indonesia continues to rise, especially with the growing elderly population and increased public awareness of eye health.

JEC itself is not a newcomer in this industry. Through the Jakarta Eye Center (JEC) network, the company has operated specialized eye hospitals and clinics in various cities for more than four decades.

Read Also: How to Buy SpaceX Tokenized Stock (SPCXon): Ondo SpaceX Tokenized Stock Guide

JEC Bali in KEK Sanur Becomes Expansion Focus

One of JECX’s biggest agendas after the IPO is the construction of JEC Bali in KEK Sanur. According to a report from Investor.id, this project is a top priority in the company’s expansion strategy.

KEK Sanur is being developed by the government as an international-standard health and medical tourism area. The presence of JEC Bali in the area is expected to serve both domestic and international patients needing eye health services with global standards.

In addition to expanding its service network, the construction of this new facility also provides an opportunity for JECX to capture growth in the specialist healthcare market, which is expected to continue rising in the coming years.

Bali’s position as an international tourist destination adds value as it has the potential to attract patients from abroad who previously chose to seek treatment in other countries.

Read Also: Can Tokenized Stocks Get Dividends? Here's How It Works

JECX Post-IPO Performance and Use of Funds

The success of the JECX IPO received a positive response from the market. According to an analysis by Pluang, JECX shares even closed at the Auto Reject Upper (ARA) level on the first trading day, reflecting high investor interest in the new issuer in the healthcare sector.

The funds obtained from the IPO will be used for several strategic needs, including:

  • construction of JEC Bali in KEK Sanur;
  • development of subsidiaries;
  • partial loan repayments;
  • operational working capital.

Read Also: US Stock Tokenization: Hold Your Favorite US Stocks and Get 7% Daily Rewards

This strategy shows that the company is striving to maintain a balance between expansion and strengthening its financial structure.

From a fundamental perspective, JECX also recorded performance growth before the IPO. Revenue increased compared to the previous year, while net profit grew around 16% to approximately Rp72.5 billion.

This improvement in profitability is one of the reasons supporting optimism about the company’s prospects after becoming a public issuer.

However, some analysts also remind that JECX stock valuation is considered quite premium compared to several other hospital issuers. Therefore, the realization of growth targets will be an important factor in maintaining investor confidence.

Read Also: 10+ Best AI Coins 2026: Here's the List of Artificial Intelligence Themed Cryptos! 

Conclusion

After the IPO, PT Nitrasanata Dharma Tbk (JECX) immediately directs its focus on two main agendas: increasing net profit by around 10% in 2026 and accelerating the construction of JEC Bali in KEK Sanur.

This strategy reflects the company’s commitment to strengthening its core business while capturing opportunities from the development of the healthcare and medical tourism sectors in Indonesia.

Going forward, JECX’s success will be largely determined by the company’s ability to realize expansion, maintain patient number growth, and preserve operational efficiency.

If these targets are achieved, JECX’s business prospects have the potential to become even more attractive amid the rising need for eye health services in Indonesia.

Monitor US stock tokens: AMZONAMDONTSLAXNFLXON MSFTON and many more. You can start trading on Bittime.

bittime low withdrawal fees

Bittime is a licensed and supervised Digital Financial Asset Trader (PAKD) by the Financial Services Authority — the place where you can buy Bitcoin in Indonesia and hundreds of other crypto assets starting from Rp10,000. Fast, secure registration process and you can start today.

Monitor  USDT to IDR conversion and real-time price movements of your favorite crypto assets. All available in one crypto investment app that can be downloaded for free on the Play Store.

Ready to start? Register now on Bittime and execute your investment strategy with a platform trusted by millions of users in Indonesia.

FAQ

What is JECX's profit target after IPO?

Management targets net profit growth of around 10% throughout 2026 through an increase in the number of patients and operational efficiency.

Why is JEC Bali being built in KEK Sanur?

KEK Sanur is being developed as a national medical tourism center, making it a strategic location to expand international-standard eye health services.

What was the market's response to the JECX IPO?

JECX shares received a positive welcome and closed at the Auto Reject Upper (ARA) level on the first trading day according to Pluang analysis.

What will the JECX IPO proceeds be used for?

IPO proceeds are allocated for the construction of JEC Bali, subsidiary development, partial loan repayments, and company working capital.

What are the future business prospects for JECX?

The prospects are considered positive, supported by growing demand for eye health services, network expansion, and the company’s strategy to sustainably increase profitability.

 

Disclaimer: The views expressed belong exclusively to the author and do not reflect the views of this platform. This platform and its affiliates disclaim any responsibility for the accuracy or suitability of the information provided. It is for informational purposes only and not intended as financial or investment advice.

Campaign Deposit Trade
Auto Earn Ramadan

Bittime Blog

Inaco Stock Prospects After IPO: Is It Attractive? JELI Analysis
Inaco Stock Prospects After IPO: Is It Attractive? JELI Analysis

Inaco (JELI) stock prospects after IPO are influenced by improving fundamentals, business expansion, and brand strength in the consumer sector.

2026-07-08Read